STAT3 and neoplasm: Lastly, we demonstrated that in xenograft NSCLC tumors, physalin A inhibited STAT3 Tyr705 phosphorylation and suppressed the in vivo tumor growth, to a degree comparable to cisplatin but with less detrimental influence to the body weight.